NCT00007592

Brief Summary

Hypertension is one of the most common medical problems in the United States and in the VA health care system. It has been well-documented that hypertension can be effectively treated. However, there remain important unresolved clinical questions in the area of antihypertensive treatment. For example, how much is mortality affected by visit compliance, blood pressure control and type of antihypertensive agent? Or, are some regimens associated with more morbidity than others? Or, are there inexpensive regimens that are as effective as more expensive regimens? The amount of data that is available from this demonstration project (currently 6,100 patients) will help address these questions. The answers to these questions should result in better care for veterans with hypertension.

Trial Health

85
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Geographic Reach
2 countries

12 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 1989

Completed
11.6 years until next milestone

First Submitted

Initial submission to the registry

December 29, 2000

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 1, 2001

Completed
Last Updated

January 21, 2009

Status Verified

February 1, 2003

First QC Date

December 29, 2000

Last Update Submit

January 20, 2009

Conditions

Keywords

Hypertensionnational data base on the treatment of hypertensioncost of different antihypertensive regimens

Interventions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Patients at Hypertension Screening and Treatment Program clinics

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (12)

Vamc - Sepulveda

Sepulveda, California, United States

Location

Vamc - Washington, Dc

Washington D.C., District of Columbia, United States

Location

Vamc - Miami

Miami, Florida, United States

Location

Vamc - Indianapolis

Indianapolis, Indiana, United States

Location

Vamc - Iowa City

Iowa City, Iowa, United States

Location

Vamc - Jackson

Jackson, Mississippi, United States

Location

Vamc - Dayton

Dayton, Ohio, United States

Location

Vamc - Philadelphia

Philadelphia, Pennsylvania, United States

Location

Vamc - Pittsburgh

Pittsburgh, Pennsylvania, United States

Location

Vamc - Memphis

Memphis, Tennessee, United States

Location

Vamc - Richmond

Richmond, Virginia, United States

Location

Vamc - San Juan, Pr

San Juan, Puerto Rico

Location

MeSH Terms

Conditions

Hypertension

Interventions

ChlorthalidoneFurosemide

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

BenzenesulfonamidesSulfonamidesAmidesOrganic ChemicalsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsBenzophenonesPhthalimidesImidesKetonesSulfonesSulfur CompoundsIsoindolesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic CompoundsSulfanilamidesAniline CompoundsAmines

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
FED

Study Record Dates

First Submitted

December 29, 2000

First Posted

January 1, 2001

Study Start

June 1, 1989

Last Updated

January 21, 2009

Record last verified: 2003-02

Locations